Federal Circuit Upholds Apple Watch Import Ban Over Masimo Patent Infringement
The legal landscape surrounding wearable technology has reached a significant milestone with the recent decision by the United States Court of Appeals for the Federal Circuit. In a high-profile ruling, the court affirmed the International Trade Commission’s earlier determination regarding a dispute over pulse oximetry technology. This decision solidifies the import ban on certain models […]
Tesla Loses CAFC Appeal in EV Charger Patent Dispute
The landscape of electric vehicle infrastructure saw a notable legal shift on February 25 2026, The United States Court of Appeals for the Federal Circuit, often referred to as the CAFC, issued a split decision that went against Tesla. This ruling upheld the validity of several patent claims held by Charge Fusion Technologies, LLC, involving […]
Broadcom takes Legal Action Against Hyundai, Nissan and Deutsche Telekom by filing a Patent Infringement Lawsuit
The global semiconductor landscape is currently witnessing a significant shift in how intellectual property is managed and defended. In a series of bold legal maneuvers, Broadcom has initiated a high-stakes Broadcom patent infringement lawsuit targeting major industry players, including automotive giants Hyundai and Nissan, as well as the European telecommunications leader Deutsche Telekom. These Patent […]
Apple Prevails Over Optis in Third Trial of 4G Wireless Patent Lawsuit
The long-standing legal battle regarding the Apple vs Optis 4G Wireless patent case has reached a significant milestone. On February 12, 2026, a federal jury in Marshall, Texas, delivered a verdict in favor of Apple Inc., concluding the third trial concerning allegations of patent infringement related to 4G LTE wireless technology. This decision marks a […]
Zydus Life and Astellas Patent Dispute Settlement: A $120 Million Resolution
The landscape of pharmaceutical intellectual property is often defined by the rigorous defense of proprietary formulations and the strategic entry of generic alternatives. Recently, a major milestone was reached in this arena as the U.S. unit of Zydus Lifesciences finalized a significant agreement with Astellas Pharma. The Zydus and Astellas Patent Dispute Settlement involves a […]
Lupin and Astellas Settle Mirabegron Patent Dispute for $90 Million
In a major industry move, Lupin Limited has settled its legal battle with Astellas Pharma over the generic version of the overactive bladder drug, Mirabegron. This Lupin and Astellas patent dispute settlement requires Lupin to pay a total of $90 million. By reaching this agreement, both companies have ended the IP litigation that previously threatened […]
Transsion Faces Multi-Country Lawsuits as Ericsson Alleges Patent Infringement
A major patent fight is making headlines worldwide, and this time it’s Ericsson taking on Transsion—the Chinese company behind Tecno, Infinix, and itel phones. Ericsson claims that Transsion has been using its 3G/4G/5G technology without the proper patent licensing, and this clash isn’t new at all. In fact, the Ericsson vs Transsion Patent Infringement Case […]
Alpha Modus Sues Adroit Worldwide Media Over Smart Retail and Cashierless Technology Patents
Patent infringement cases have become pretty common in today’s business world, and now another one is making headlines. This time, it’s about Alpha Modus Holdings blaming Adroit Worldwide Media (AWM) for using its patented technologies without permission. The Alpha Modus vs AWM case is a clear reminder of how valuable intellectual property can be and […]
US Tech Firm Natsoft Drags Hexaware Into $500M Patent Fight
Hexaware Technologies, a leading Indian IT services company, is facing a massive $500 million lawsuit filed by US-based Natsoft Corporation and its subsidiary Updraft. Natsoft vs Hexaware patent case The case revolves around alleged contract violations and patent infringement, making it one of the biggest intellectual property rights (IPR) disputes in the IT sector. This […]
AstraZeneca Faces and Cellectis Inc. Patent Infringement Lawsuit by Factor Bioscience Over mRNA Gene-Editing Tech
A major patent dispute is making headlines in the pharmaceutical world, involving three big names in biotech and drug development. mRNA TALEN patent infringement case Factor Bioscience Inc., a U.S.-based biotech company, has filed a patent infringement lawsuit against AstraZeneca PLC (a UK-based pharmaceutical giant) and Cellectis Inc. (a French-American biopharmaceutical firm). Factor Bioscience accuses […]
- 1
- 2